CAS RN: 25597-09-5
STEAROYL-L-CARNITINE
Product Availability
Choose a grade to view its available package options.
7 package records6 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250331 |
5mg / 10mg / 50mg / 250mg |
Confirm by inquiry |
Shanghai, Shandong | 1 business days | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250524 |
100mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250715 |
10mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260225 |
1g |
Out of stock |
| | Inquiry |
| Batchno.20251204 |
250mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20251226 |
25mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250520 |
50mg |
In stock |
Shanghai | | Inquiry |
-
Product code:
starshine_CAS25597-09-5
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
25597-09-5 / 3-octadecanoyloxy-4-(trimethylazaniumyl)butanoate
Standard CAS: 25597-09-5
Multi CAS: No
Basic Information
CAS
25597-09-5
Multi CAS
No
Molecular Formula
C25H49NO4
Molecular Weight
427.700000
Exact Mass
427.366159
SMILES
CCCCCCCCCCCCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C
InChI
InChI=1S/C25H49NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(21-24(27)28)22-26(2,3)4/h23H,5-22H2,1-4H3
InChIKey
FNPHNLNTJNMAEE-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
30
Fraction Csp3
0.92
Rotatable bonds
21
H-bond acceptors
4
Molar refractivity
121.95
TPSA
66.43
LogP / Solubility
WLOGP
5.01
MLOGP
4.43
XLogP3
8.8
Consensus LogP
6.08
Log S (ESOL)
-4.26
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.68
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-9.11
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.77
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
No
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
3